Basic information Safety Supplier Related

(1S-cis)-Milnacipran Hydrochloride

Basic information Safety Supplier Related

(1S-cis)-Milnacipran Hydrochloride Basic information

Product Name:
(1S-cis)-Milnacipran Hydrochloride
Synonyms:
  • (1S,2R)-2-(AMinoMethyl)-N,N-diethyl-1-phenylcyclopropanecarboxaMide Hydrochloride
  • (1S-cis)-Milnacipran Hydrochloride
  • LevoMilnacipran hydrochloride
  • (1S,2R)-Milnacipran hydrochloride
  • F 2695 hydrochloride
  • Milnacipran (1S-cis)
  • Levomilnacipran HCl
  • Milnacipran ((1S-cis) hydrochloride)
CAS:
175131-60-9
MF:
C15H23ClN2O
MW:
282.81
Product Categories:
  • Amines
  • Aromatics
  • Chiral Reagents
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
Mol File:
175131-60-9.mol
More
Less

(1S-cis)-Milnacipran Hydrochloride Chemical Properties

storage temp. 
Store at -20°C
solubility 
DMSO:57.0(Max Conc. mg/mL);201.55(Max Conc. mM)
form 
A crystalline solid
color 
White to off-white
More
Less

(1S-cis)-Milnacipran Hydrochloride Usage And Synthesis

Description

Levomilnacipran (Fetzima®) is a dual serotonin–norepinephrine reuptake inhibitor (SNRI) approved by the FDA in 2013 for the treatment of major depressive disorders (MDD). Levomilnacipran is the most active enantiomer of the racemate Milnacipran, which is currently used to treat pain associated with fibromyalgia. The drug was developed by Forest Laboratories and the Pierre Fabre group.

Uses

The (1S-cis)-enatiomer of Milnacipran (M344600). A selective norepinephrine and serotonin reuptake inhibitor approved for the management of fibromyalgia.

Uses

The S-enatiomer of Milnacipran (M344600).

Synthesis

Reaction of phenylacetonitrile (100) and commercially available (R)-epichlorohydrin (101) with NaNH2 led to chloride displacement and intramolecular cyclopropanation, yielding lactone 102 after a one-pot nitrile hydrolysis and acid-promoted lactonization (75% yield over 3 steps). Lactone ring-opening with Et2NH¨CAlCl3 complex provided amido-alcohol 103, which was converted to its phthalimido derivative 104 by sequential treatment with thionyl chloride and potassium phthalimide in 80% over three steps. Finally, levomilnacipran hydrochloride (XIII) was obtained in >95% optical purity after phthalimide cleavage, HCl salt formation, and crystallization from HCl/i-PrOH/i-PrAc. This sequence represents a highly efficient route to levomilnacipran, requiring no isolation of intermediates, resulting in >40% overall yield, and allowing use of the same solvent solution (toluene) for all steps.

(1S-cis)-Milnacipran HydrochlorideSupplier

Hangzhou Lenny Technology Co. , Ltd. Gold
Tel
571-88086013
Email
sunnie@rdpharm.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Suzhou Zehou Biotechnology Co. , Ltd.
Tel
0512-68716880 19984816880
Email
sales@growingchem.com
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Email
chenyj@titansci.com